Clinical Trial Update: DIM as a Treatment for Thyroid Disease [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports the termination of an early Phase 1 study evaluating Diindolylmethane (DIM) as a treatment for thyroid disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Disease

Drugs mentioned

• Diindolylmethane (DIM) (Diindolylmethane)

Snippet

Sponsor: The New York Eye & Ear Infirmary | Conditions: Proliferative Thyroid Disease | EARLY_Phase 1 | Status: TERMINATED